In Vitro Activity of Melaleuca alternifolia (Tea Tree) in Its Free Oil and Nanoemulsion Formulations Against Pythium insidiosum
- 266 Downloads
Pythium insidiosum is an important aquatic oomycete which can cause pythiosis in both animals and humans. This microorganism shows low susceptibility to antifungal drugs available. This study analyzed the in vitro antimicrobial activity of Melaleuca alternifolia in its free oil (FO) and nanoemulsion (NE) formulations against Brazilian P. insidiosum isolates. The antimicrobial activity evaluation was performed by the broth microdilution method according to CSLI M38-A2 document adapted to phytopharmaceuticals. Twenty-six P. insidiosum isolates were evaluated, and the minimum inhibitory concentration was determined at 100 % growth inhibition. Melaleuca alternifolia essential oil or FO was obtained commercially. The NE containing 1 % M. alternifolia essential oil was prepared by the spontaneous emulsification method. All P. insidiosum isolates evaluated showed minimum inhibitory concentrations (MIC) ranging from 531.5 to 2125 μg/mL for the FO formulation; MIC50 and MIC90 showed values between 1062.5 and 2125 μg/mL, respectively. When the NE formulation was evaluated, MIC values ranged from 132.7 to 2125 μg/mL and both MIC50 and MIC90 corresponded to 1062.5 μg/mL. FO and NE formulations of M. alternifolia showed antimicrobial activity against P. insidiosum. This study demonstrated that M. alternifolia oil can be an additional therapy in pythiosis treatment; however, further studies are needed to evaluate the applicability of the plant essential oils in the treatment of clinical pythiosis.
KeywordsOomycete Pythiosis Medicinal plants Nanostructured systems
The authors are grateful to Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (FAPERGS) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) [Process: 442,020/2014-7] for their financial support, and student and research grants.
Compliance with Ethical Standards
Conflicts of interest
None of the authors of this manuscript has a financial or personal relationship with other people or organizations that could inappropriately influence the content of this work.
- 3.Fonseca AOF, Pereira DIB, Jacob RG, Maia Filho FS, Oliveira DH, Maroneze BP, Valente JSS, Osório LG, Botton SA, Meireles MCA. In vitro susceptibility of Brazilian Pythium insidiosum isolates to essential oils of some Lamiaceae family species. Mycopathologia. 2015;179:253–8.CrossRefPubMedGoogle Scholar
- 4.Fonseca AOS, Pereira DIB, Botton SA, Pötter L, Sallis ESV, Júnior SFV, Filho FSM, Zambrano CG, Maroneze BP, Valente JSS, Baptista CT, Braga CQ, Dal Ben V, Meireles MCA. Treatment of experimental pythiosis with essential oils of Origanum vulgare and Mentha piperita singly, in association and in combination with immunotherapy. Vet Microbiol. 2015;5:265–9.CrossRefGoogle Scholar
- 8.Valente JSS, Fonseca AOS, Denardi LB, Dal Ben VS, Maia Filho FS, Baptista CT, Braga CQ, Zambrano CG, Alves SH, Botton SA, Pereira DIB. In vitro susceptibility of Pythium insidiosum to Melaleuca alternifolia, Mentha piperita and Origanum vulgare essential oils combinations. Mycopathologia. 2016;18:1–6.Google Scholar
- 12.Baldissera MD, Silva AS, Oliveira CBA, Santos RCV, Rodrigo A, Vaucher RA, Raffin RP, Gomes P, Dambros MGC, Miletti LC, Boligon AA, Athayde ML, Monteiro SG. Trypanocidal action of tea tree oil (Melaleuca alternifolia) against Trypanosoma evansi in vitro and in vivo used mice as experimental model. Exp Parasitol. 2014;141:21–7.CrossRefPubMedGoogle Scholar
- 17.Souza ME, Lopes LQS, Vaucher RA, Mário DN, Alves SH, Agertt VA, Bianchini BV, Felicidade SI, Campus MMA, Boligon AA, Athayde ML, Santos CG, Raffin RP, Gomes P, Santos RCV. Antimycobacterial and antifungal activities of Melaleuca alternifolia oil nanoparticles. J Drug Del Sci Technol. 2014;24:559–60.CrossRefGoogle Scholar
- 21.Rex JH, Alexander BD, Andes D, Arthington-Skaggs B, Brown SD, Chaturveli V, Espingel-Ingroff A, Ghannoum MA, Knapp CC, Motyl MR, Ostrosky-Zeichner L, Pfaller M, Sheehan DJ, Walsh TJ. Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: approved standard, 2nd ed. Wayne: M38-A2 CLSI. 2008;28:1–35.Google Scholar